Furthermore, immunohistochemical studies using specific antibodies against serine 473-phosphorylated AKT have shown that the AKT activity is detectable in various cancers, including melanoma and cancers of the head and neck, ovary, pancreas, stomach and prostate25, 27, 28, 29, 30, 31. Here, AKT1 is linked to melanoma.